In conclusion, our study clearly shows the capability of SOX9+ BCs to regenerate human lung, proves the concept of chronic lung disease treatment by SOX9+ BC transplantation and provides exciting translational opportunities in near future. This evidence concerns the gene SOX9 and chronic lung disease.